At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
WGS GeneDx Holdings
Not Yet Opened 11-21 16:00:00 EST
72.07
+2.69
+3.88%
盘后73.00
+0.93+1.29%
19:40 EST
High75.49
Low69.00
Vol675.48K
Open69.16
D1 Closing69.38
Amplitude9.35%
Mkt Cap1.98B
Tradable Cap1.35B
Total Shares27.47M
T/O49.37M
T/O Rate3.60%
Tradable Shares18.77M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
GeneDx Fuels Rare Disease Drug Discovery with Launch of GeneDx Discover
GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It also provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. is headquartered in Stamford, Connecticut.